BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)

Clinical trial NCT05922761 · RECRUITING

Trial details

NCT number: NCT05922761
Sponsor: Dana-Farber Cancer Institute
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Bronchiolitis Obliterans Syndrome Bronchiolitis Obliterans Lung Diseases Chronic Graft Versus Host Disease

Start date: 2024-05-31
Primary completion: 2027-06-30
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.